Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
This report aims to provide a comprehensive presentation of the global market for Drugs for Schistosomiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Schistosomiasis. This report contains market size and forecasts of Drugs for Schistosomiasis in global, including the following market information:
Global Drugs for Schistosomiasis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drugs for Schistosomiasis Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Drugs for Schistosomiasis companies in 2022 (%)
The global Drugs for Schistosomiasis market was valued at US$ 84 million in 2022 and is projected to reach US$ 108.3 million by 2029, at a CAGR of 3.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
We surveyed the Drugs for Schistosomiasis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Schistosomiasis Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Drugs for Schistosomiasis Market Segment Percentages, by Type, 2022 (%)
Praziquantel
Oxamniquine
Other
Global Drugs for Schistosomiasis Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Drugs for Schistosomiasis Market Segment Percentages, by Application, 2022 (%)
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Global Drugs for Schistosomiasis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Drugs for Schistosomiasis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Schistosomiasis revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drugs for Schistosomiasis revenues share in global market, 2022 (%)
Key companies Drugs for Schistosomiasis sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Drugs for Schistosomiasis sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Schistosomiasis, market overview.
Chapter 2: Global Drugs for Schistosomiasis market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs for Schistosomiasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Schistosomiasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs for Schistosomiasis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Schistosomiasis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Schistosomiasis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Schistosomiasis Overall Market Size
2.1 Global Drugs for Schistosomiasis Market Size: 2022 VS 2029
2.2 Global Drugs for Schistosomiasis Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drugs for Schistosomiasis Sales: 2018-2029
3 Company Landscape
3.1 Top Drugs for Schistosomiasis Players in Global Market
3.2 Top Global Drugs for Schistosomiasis Companies Ranked by Revenue
3.3 Global Drugs for Schistosomiasis Revenue by Companies
3.4 Global Drugs for Schistosomiasis Sales by Companies
3.5 Global Drugs for Schistosomiasis Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drugs for Schistosomiasis Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drugs for Schistosomiasis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Schistosomiasis Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Schistosomiasis Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Schistosomiasis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Schistosomiasis Market Size Markets, 2022 & 2029
4.1.2 Praziquantel
4.1.3 Oxamniquine
4.1.4 Other
4.2 By Type - Global Drugs for Schistosomiasis Revenue & Forecasts
4.2.1 By Type - Global Drugs for Schistosomiasis Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Schistosomiasis Revenue, 2024-2029
4.2.3 By Type - Global Drugs for Schistosomiasis Revenue Market Share, 2018-2029
4.3 By Type - Global Drugs for Schistosomiasis Sales & Forecasts
4.3.1 By Type - Global Drugs for Schistosomiasis Sales, 2018-2023
4.3.2 By Type - Global Drugs for Schistosomiasis Sales, 2024-2029
4.3.3 By Type - Global Drugs for Schistosomiasis Sales Market Share, 2018-2029
4.4 By Type - Global Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Schistosomiasis Market Size, 2022 & 2029
5.1.2 S. haematobium
5.1.3 S. mansoni
5.1.4 S. japonicum
5.1.5 S. mekongi
5.1.6 S. intercalatum
5.2 By Application - Global Drugs for Schistosomiasis Revenue & Forecasts
5.2.1 By Application - Global Drugs for Schistosomiasis Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Schistosomiasis Revenue, 2024-2029
5.2.3 By Application - Global Drugs for Schistosomiasis Revenue Market Share, 2018-2029
5.3 By Application - Global Drugs for Schistosomiasis Sales & Forecasts
5.3.1 By Application - Global Drugs for Schistosomiasis Sales, 2018-2023
5.3.2 By Application - Global Drugs for Schistosomiasis Sales, 2024-2029
5.3.3 By Application - Global Drugs for Schistosomiasis Sales Market Share, 2018-2029
5.4 By Application - Global Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Drugs for Schistosomiasis Market Size, 2022 & 2029
6.2 By Region - Global Drugs for Schistosomiasis Revenue & Forecasts
6.2.1 By Region - Global Drugs for Schistosomiasis Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Schistosomiasis Revenue, 2024-2029
6.2.3 By Region - Global Drugs for Schistosomiasis Revenue Market Share, 2018-2029
6.3 By Region - Global Drugs for Schistosomiasis Sales & Forecasts
6.3.1 By Region - Global Drugs for Schistosomiasis Sales, 2018-2023
6.3.2 By Region - Global Drugs for Schistosomiasis Sales, 2024-2029
6.3.3 By Region - Global Drugs for Schistosomiasis Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Drugs for Schistosomiasis Revenue, 2018-2029
6.4.2 By Country - North America Drugs for Schistosomiasis Sales, 2018-2029
6.4.3 US Drugs for Schistosomiasis Market Size, 2018-2029
6.4.4 Canada Drugs for Schistosomiasis Market Size, 2018-2029
6.4.5 Mexico Drugs for Schistosomiasis Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Drugs for Schistosomiasis Revenue, 2018-2029
6.5.2 By Country - Europe Drugs for Schistosomiasis Sales, 2018-2029
6.5.3 Germany Drugs for Schistosomiasis Market Size, 2018-2029
6.5.4 France Drugs for Schistosomiasis Market Size, 2018-2029
6.5.5 U.K. Drugs for Schistosomiasis Market Size, 2018-2029
6.5.6 Italy Drugs for Schistosomiasis Market Size, 2018-2029
6.5.7 Russia Drugs for Schistosomiasis Market Size, 2018-2029
6.5.8 Nordic Countries Drugs for Schistosomiasis Market Size, 2018-2029
6.5.9 Benelux Drugs for Schistosomiasis Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Drugs for Schistosomiasis Revenue, 2018-2029
6.6.2 By Region - Asia Drugs for Schistosomiasis Sales, 2018-2029
6.6.3 China Drugs for Schistosomiasis Market Size, 2018-2029
6.6.4 Japan Drugs for Schistosomiasis Market Size, 2018-2029
6.6.5 South Korea Drugs for Schistosomiasis Market Size, 2018-2029
6.6.6 Southeast Asia Drugs for Schistosomiasis Market Size, 2018-2029
6.6.7 India Drugs for Schistosomiasis Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Drugs for Schistosomiasis Revenue, 2018-2029
6.7.2 By Country - South America Drugs for Schistosomiasis Sales, 2018-2029
6.7.3 Brazil Drugs for Schistosomiasis Market Size, 2018-2029
6.7.4 Argentina Drugs for Schistosomiasis Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Drugs for Schistosomiasis Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Drugs for Schistosomiasis Sales, 2018-2029
6.8.3 Turkey Drugs for Schistosomiasis Market Size, 2018-2029
6.8.4 Israel Drugs for Schistosomiasis Market Size, 2018-2029
6.8.5 Saudi Arabia Drugs for Schistosomiasis Market Size, 2018-2029
6.8.6 UAE Drugs for Schistosomiasis Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shin Poong
7.1.1 Shin Poong Company Summary
7.1.2 Shin Poong Business Overview
7.1.3 Shin Poong Drugs for Schistosomiasis Major Product Offerings
7.1.4 Shin Poong Drugs for Schistosomiasis Sales and Revenue in Global (2018-2023)
7.1.5 Shin Poong Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Drugs for Schistosomiasis Major Product Offerings
7.2.4 Merck Drugs for Schistosomiasis Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Drugs for Schistosomiasis Major Product Offerings
7.3.4 Bayer Drugs for Schistosomiasis Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 EIPICO
7.4.1 EIPICO Company Summary
7.4.2 EIPICO Business Overview
7.4.3 EIPICO Drugs for Schistosomiasis Major Product Offerings
7.4.4 EIPICO Drugs for Schistosomiasis Sales and Revenue in Global (2018-2023)
7.4.5 EIPICO Key News & Latest Developments
7.5 Chandra Bhagat Pharma
7.5.1 Chandra Bhagat Pharma Company Summary
7.5.2 Chandra Bhagat Pharma Business Overview
7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Major Product Offerings
7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales and Revenue in Global (2018-2023)
7.5.5 Chandra Bhagat Pharma Key News & Latest Developments
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Company Summary
7.6.2 Taj Pharmaceuticals Business Overview
7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Major Product Offerings
7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales and Revenue in Global (2018-2023)
7.6.5 Taj Pharmaceuticals Key News & Latest Developments
8 Global Drugs for Schistosomiasis Production Capacity, Analysis
8.1 Global Drugs for Schistosomiasis Production Capacity, 2018-2029
8.2 Drugs for Schistosomiasis Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Schistosomiasis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Schistosomiasis Supply Chain Analysis
10.1 Drugs for Schistosomiasis Industry Value Chain
10.2 Drugs for Schistosomiasis Upstream Market
10.3 Drugs for Schistosomiasis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Schistosomiasis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Drugs for Schistosomiasis in Global Market
Table 2. Top Drugs for Schistosomiasis Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Drugs for Schistosomiasis Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Drugs for Schistosomiasis Revenue Share by Companies, 2018-2023
Table 5. Global Drugs for Schistosomiasis Sales by Companies, (M Units), 2018-2023
Table 6. Global Drugs for Schistosomiasis Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Drugs for Schistosomiasis Price (2018-2023) & (USD/K Units)
Table 8. Global Manufacturers Drugs for Schistosomiasis Product Type
Table 9. List of Global Tier 1 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Drugs for Schistosomiasis Sales (M Units), 2018-2023
Table 15. By Type - Global Drugs for Schistosomiasis Sales (M Units), 2024-2029
Table 16. By Application ? Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Drugs for Schistosomiasis Sales (M Units), 2018-2023
Table 20. By Application - Global Drugs for Schistosomiasis Sales (M Units), 2024-2029
Table 21. By Region ? Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Drugs for Schistosomiasis Sales (M Units), 2018-2023
Table 25. By Region - Global Drugs for Schistosomiasis Sales (M Units), 2024-2029
Table 26. By Country - North America Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Drugs for Schistosomiasis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Drugs for Schistosomiasis Sales, (M Units), 2018-2023
Table 29. By Country - North America Drugs for Schistosomiasis Sales, (M Units), 2024-2029
Table 30. By Country - Europe Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Drugs for Schistosomiasis Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Drugs for Schistosomiasis Sales, (M Units), 2018-2023
Table 33. By Country - Europe Drugs for Schistosomiasis Sales, (M Units), 2024-2029
Table 34. By Region - Asia Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Drugs for Schistosomiasis Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Drugs for Schistosomiasis Sales, (M Units), 2018-2023
Table 37. By Region - Asia Drugs for Schistosomiasis Sales, (M Units), 2024-2029
Table 38. By Country - South America Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Drugs for Schistosomiasis Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Drugs for Schistosomiasis Sales, (M Units), 2018-2023
Table 41. By Country - South America Drugs for Schistosomiasis Sales, (M Units), 2024-2029
Table 42. By Country - Middle East & Africa Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Drugs for Schistosomiasis Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Drugs for Schistosomiasis Sales, (M Units), 2018-2023
Table 45. By Country - Middle East & Africa Drugs for Schistosomiasis Sales, (M Units), 2024-2029
Table 46. Shin Poong Company Summary
Table 47. Shin Poong Drugs for Schistosomiasis Product Offerings
Table 48. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2018-2023)
Table 49. Shin Poong Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Drugs for Schistosomiasis Product Offerings
Table 52. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Drugs for Schistosomiasis Product Offerings
Table 56. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. EIPICO Company Summary
Table 59. EIPICO Drugs for Schistosomiasis Product Offerings
Table 60. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2018-2023)
Table 61. EIPICO Key News & Latest Developments
Table 62. Chandra Bhagat Pharma Company Summary
Table 63. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offerings
Table 64. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2018-2023)
Table 65. Chandra Bhagat Pharma Key News & Latest Developments
Table 66. Taj Pharmaceuticals Company Summary
Table 67. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offerings
Table 68. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2018-2023)
Table 69. Taj Pharmaceuticals Key News & Latest Developments
Table 70. Drugs for Schistosomiasis Production Capacity (M Units) of Key Manufacturers in Global Market, 2021-2023 (M Units)
Table 71. Global Drugs for Schistosomiasis Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Drugs for Schistosomiasis Production by Region, 2018-2023 (M Units)
Table 73. Global Drugs for Schistosomiasis Production by Region, 2024-2029 (M Units)
Table 74. Drugs for Schistosomiasis Market Opportunities & Trends in Global Market
Table 75. Drugs for Schistosomiasis Market Drivers in Global Market
Table 76. Drugs for Schistosomiasis Market Restraints in Global Market
Table 77. Drugs for Schistosomiasis Raw Materials
Table 78. Drugs for Schistosomiasis Raw Materials Suppliers in Global Market
Table 79. Typical Drugs for Schistosomiasis Downstream
Table 80. Drugs for Schistosomiasis Downstream Clients in Global Market
Table 81. Drugs for Schistosomiasis Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drugs for Schistosomiasis Segment by Type in 2022
Figure 2. Drugs for Schistosomiasis Segment by Application in 2022
Figure 3. Global Drugs for Schistosomiasis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Schistosomiasis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Schistosomiasis Revenue, 2018-2029 (US$, Mn)
Figure 7. Drugs for Schistosomiasis Sales in Global Market: 2018-2029 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Schistosomiasis Revenue in 2022
Figure 9. By Type - Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 11. By Type - Global Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 12. By Type - Global Drugs for Schistosomiasis Price (USD/K Units), 2018-2029
Figure 13. By Application - Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 15. By Application - Global Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 16. By Application - Global Drugs for Schistosomiasis Price (USD/K Units), 2018-2029
Figure 17. By Region - Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Drugs for Schistosomiasis Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 20. By Region - Global Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 21. By Country - North America Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 22. By Country - North America Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 23. US Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 28. Germany Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 29. France Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 37. China Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 41. India Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 43. By Country - South America Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 44. Brazil Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Drugs for Schistosomiasis Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Drugs for Schistosomiasis Sales Market Share, 2018-2029
Figure 48. Turkey Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Drugs for Schistosomiasis Revenue, (US$, Mn), 2018-2029
Figure 52. Global Drugs for Schistosomiasis Production Capacity (M Units), 2018-2029
Figure 53. The Percentage of Production Drugs for Schistosomiasis by Region, 2022 VS 2029
Figure 54. Drugs for Schistosomiasis Industry Value Chain
Figure 55. Marketing Channels
